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Abstract: Salar de Huasco at the Chilean Altiplano of the Atacama Desert is considered a polyextreme
environment, where solar radiation, salinity and aridity are extremely high and occur simultaneously.
In this study, a total of 76 bacterial isolates were discovered from soil samples collected at two different
sites in the east shoreline of Salar de Huasco, including H0 (base camp next to freshwater stream in the
north part) and H6 (saline soils in the south part). All isolated bacteria were preliminarily identified
using some of their phenotypic and genotypic data into the genera Streptomyces (86%), Nocardiopsis
(9%), Micromonospora (3%), Bacillus (1%), and Pseudomonas (1%). Streptomyces was found dominantly
in both sites (H0 = 19 isolates and H6 = 46 isolates), while the other genera were found only in
site H0 (11 isolates). Based on the genotypic and phylogenetic analyses using the 16S rRNA gene
sequences of all Streptomyces isolates, 18% (12 isolates) revealed <98.7% identity of the gene sequences
compared to those in the publicly available databases and were determined as highly possibly novel
species. Further studies suggested that many Streptomyces isolates possess the nonribosomal peptide
synthetases-coding gene, and some of which could inhibit growth of at least two test microbes (i.e.,
Gram-positive and Gram-negative bacteria and fungi) and showed also the cytotoxicity against
hepatocellular carcinoma and or mouse fibroblast cell lines. The antimicrobial activity and cytotoxicity
of these Streptomyces isolates were highly dependent upon the nutrients used for their cultivation.
Moreover, the HPLC-UV-MS profiles of metabolites produced by the selected Streptomyces isolates
unveiled apparent differences when compared to the public database of existing natural products.
With our findings, the polyextreme environments like Salar de Huasco are promising sources for
exploring novel and valuable bacteria with pharmaceutical potentials.
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1. Introduction
Actinomycetes are the most important bacteria that are capable of producing bioactive compounds.
The majority of natural products for new pharmaceutical applications are derived from actinomycetes [1],
while the notable member of actinomycetes, the genus Streptomyces is the major producer [2]. Many
of these specialized metabolites biosynthesized by actinomycetes correspond to polyketides and
nonribosomal peptides, which may act as antibiotics, immunosuppressants, anticancer/antitumor
agents, toxins, and siderophores [3]. The members of the genus Streptomyces are widely distributed
across various habitats and geographical locations [4]. Streptomyces produces spores that are
characteristically resistant, allowing this bacterium to persist in the extreme environments and
to maintain its viability for many years [5]. Previous studies showed that bacteria isolated from the
extreme environments, such as the Mariana Trench [6], the polar and permafrost soils in the Arctic [7,8],
and the extremely dry and saline soils of the Atacama Desert [9] are unique sources for the discovery
of new bioactive compounds and many of them are possibly novel species [5,10,11].
The Atacama Desert is the driest place in the world located in South America, precisely in Chile,
covering a 1000-km strip of land on the Pacific coast, west of the Andes Mountains. It is bordering
Peru in the north and extending to the Copiapó River in the south. Nowadays, four novel Streptomyces
species derive from this extreme desert, including Streptomyces atacamensis [12], Streptomyces desertii [13],
Streptomyces bulli [14], and Streptomyces leeuwenhoekii [15]. S. leeuwenhoekii is the producer of two
newly bioactive compounds comprised of (i) chaxamycins, showing antagonism against Staphylococcus
aureus ATCC 25923, inhibiting the heat shock protein 90, and degrading proteins involved in cell
proliferation [9] and (ii) chaxalactins, the anti-Gram-positive bacterial agents [16]. Two more novel
compounds, atacamycins and chaxapeptin, each derive respectively from Streptomyces sp., C38 [17] and
C58 [18] isolated from hyper-arid soil of the Laguna de Chaxa of Salar de Atacama in the north of Chile
(a lagoon located in the commune of San Pedro de Atacama, province of El Loa). These two compounds
are novel lasso-peptides produced by nonribosomal biosynthesis with post-translational modification
and capable of inhibiting human lung cancer cell line A549. Another group of new compounds with
antimicrobial activity, the abenquines A–D, was obtained from Streptomyces sp. DB634 isolated from
the Salar de Tara in the Chilean Altiplano (>4000 m.a.s.l.) [19].
In Chile, the Chilean Altiplano of the Atacama Desert, is considered the highest plateau of the
Andes Mountains (>3000 m.a.s.l.) with 14◦ to 22◦ S of latitude, in addition, it is subjected to strong
climatic variation over different temporal scales [19]. This site offers a unique ecosystem with highly
extreme conditions, such as changes in daily temperature from −10 to +25 ◦C [19] and it divides into
different sites, for instance, Salar de Tara (at 150 km east of the town of San Pedro de Atacama, in the
Province of El Loa, region Antofagasta) and Salar de Huasco (in the south of the town of Parinacota
in the Arica and Parinacota regions). The Salar de Huasco is known by its polyextreme conditions,
i.e., salinity gradient (from freshwater to saturation), elevated levels of solar radiation (<1100 W/m2),
and negative water balance, which differs from the other locations previously studied in the Atacama
Desert. Some areas of the Salar de Huasco have been found to house diverse microbes [20,21]. However,
there is no study regarding the cultivable actinomycetes from this polyextreme ecosystem and their
pharmaceutical potentials. Here, we aim to isolate bacteria with a focus on actinomycetes from different
sites of the Salar de Huasco and to assess their pharmaceutical potentials in possession of nonribosomal
peptide synthases (NRPS)-coding gene, antimicrobial activity, and cytotoxicity.
2. Materials and Methods
2.1. Isolation of Actinomyces
Six soil samples were collected from sites H0 (base camp; freshwater stream) and H6 (saline
soils) located in the northern and southern parts of the eastern shoreline of the Salar de Huasco,
respectively [22] (Figure 1). Sites H0 and H6 were characterized as meso-saline and hyper saline sites
with pH 7.6 and pH 8.6, respectively [23]. The samples were taken at 5 cm depth from the ground
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surface using sterile polypropylene tubes and transferred to the laboratory. These samples were stored
at ambient temperature for a period not exceeding 5 days. One g of soil sample was suspended in 9 mL
of 14 strength Ringer’s solution, and 1 mL of the soil suspension was diluted 100-fold and mixed in an
orbital shaker at 150 rpm for 1 h. The diluted soil suspension was pretreated by heating at 55 ◦C for
6 min in a thermo-regulated bath [4]. The heated aliquot (0.1 mL) was spread over the surface of starch
casein agar medium (SCA), supplemented with 50 µg/mL nystatin and 50 µg/mL cycloheximide to
prevent fungal contamination [24]. All seeded agar plates were prepared in triplicate and incubated at
28 ◦C for 14–21 days [25]. Colonies with rough appearance, powdery or tough texture and branching
filaments with and without aerial mycelia were subcultured on SCA plates and incubated at 28 ◦C
for 14 days. A subculture of each isolate was prepared on International Streptomyces Project III (ISP3)
medium [26] under the same condition cited above. The purity of the each isolates was checked using
light microscope.
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Figure 1. 1: Satellite image of Salar de Huasco indicating sampling sites. Image Google Earth V
7.3.2.5776. (3 March 2019). Salar de Huasco, Chile. 20◦16′22.68” S, 68◦52′54.08′ W, Eye alt 14.35
mi. CNES/Airbus 2019 [30 March 2019]. https://earth.google.com/web/@-20.29749527,-68.84083051,
3780.51679815a,17347.67437889d,35y,360h,0t,0r. 2: Sampling sites at Salar de Huasco, Northern Chile.
(A) Panoramic view of Salar de Huasco, Chilean Altiplano; (B) Site H0, saline crusts; (C) Site H6, soils;
(D) Site H6, saline soils.
2.2. Identification of Bacterial Isolates
2.2.1. Morphological Characterization Based on Color Grouping
The morphological characteristics of all bacterial isolates grown on ISP3 medium, such as aerial
spore mass color, pigmentation of vegetative or substrate mycelium, and the production of diffusible
pigment were examined. The color of the aerial and substrate mycelium of the isolates were described
referring to the National Bureau of Standards (NBS) Color Name Charts [27]. Each isolate was
maintained on glucose yeast extract and malt extract (GYM) medium and stored as spore suspensions
and hyphae in 25% (v/v) glycerol at −80 ◦C.
2.2.2. 16S rRNA Gene-Based Phylogenetic Analysis
Bacterial cultures were prepared in tryptone yeast extract (ISP1) broth at 28 ◦C for 7 days, in which
2 mL was transferred to vials containing 0.5 mm glass beads (BioSpec Products Inc, Bartlesville, OK,
USA) to breakdown mechanically the bacterial cells (Mini Bead Beater, Bead Homogenizer, BioSpec
Products Inc, Bartlesville, OK, USA). Total genomic DNA was extracted from the homogenized bacterial
suspension using the AxyPrep Bacterial Genomic DNA Miniprep kit (Axygen Biosciences, Union City,
NJ, USA) as recommended by the manufacturer.
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The 16S rRNA gene was amplified by PCR using the universal primers for bacteria, Eub9-27F
and Eub1542R [28]. Every reaction was performed in a final volume of 50 µL, containing 50–100 ng of
genomic DNA, 2.0 µM of each primer, 19 µL of nuclease-free MilliQ-H2O (Merck Millipore, Burlington,
MA, USA), and 25 µL of SapphireAmp® Fast PCR Master Mix (TaKaRa, Japan). PCR was carried out
in a thermocycler under the following conditions: Initial denaturation at 94 ◦C for 5 min, 30 cycles of
denaturation at 94 ◦C for 45 s, annealing at 54 ◦C for 45 s, and extension at 72 ◦C for 1.5 min, and a
final extension at 72 ◦C for 5 min. The PCR (Polymerase Chain Reaction) products were checked by 1%
(w/v) agarose gel electrophoresis and subsequently sequenced by capillary sequencing using an ABI
Prism 3730XL automated DNA sequencer (Applied Biosystems, Macrogen Inc., Seoul, Korea).
The 16S rRNA gene sequences were analyzed and edited using the software DNA Baser Sequence
Assembler version 3.5 (Heracle BioSoft SRL, 2014). The partial 16S rRNA gene sequences of the isolates
were aligned using RDP II [29]. EzTaxon [30] was used to retrieve the nearest phylogenetic neighbors
of all bacterial isolates. The nearly completed 16S rRNA gene sequences (>1300 nt) of the isolates were
deposited in the GenBank database with the accession numbers KX130868-KX130886.
The phylogenetic tree was constructed using Neighbor-Joining algorithms [31] with a Tamura-Nei
substitution model using MEGA 7.0 software [32]. The multiple alignments of all the 16S rRNA gene
sequences were performed using MUSCLE (MUltiple Sequence Comparison by Log- Expectation)
algorithm [33]. The robustness of the tree was evaluated using 1000 Bootstrap [34].
2.3. Evaluations of Pharmaceutical Potentials
2.3.1. Genotyping of Nonribosomal Peptide Synthetase (NRPS)
Streptomyces isolates with nearly complete 16S rRNA gene sequences were screened for the presence
of nonribosomal peptide synthetase (NRPS) domains using the primers A3F (5′-GCSTACSYSATS
TACACSTCSGG-3′) and A7R (5′-SASGTCVCCSGTSCGGTAS-3′) following a method described by
Ayuso-Sacido and Genilloud [35].
2.3.2. Preparation of Crude Extracts and Bioactivity Assessments
The secondary metabolites were extracted from Streptomyces isolates possessing NRPS domains
following a protocol described by Schneemann et al. [36] with some modifications. Each isolate was
grown in 100 mL of GYM (pH 7.2), and in starch-soy peptone (SPM, pH 7.0) liquid media supplemented
with 2% NaCl and incubated at 28 ◦C for one week, with shaking at 135 rpm, in an orbital shaking
incubator (MaxQ 4000, Thermo Fisher Scientific, Waltham, MA, USA). Extraction of metabolites from
the whole culture broths started with the addition of 150 mL of ethyl acetate to each flask, followed
by stirring and sonication cycles and kept at 4 ◦C overnight for effective phase separation. The
lower aqueous phase was discarded, and the ethyl acetate phase (supernatant) was dried in a rotary
evaporator (Büchi, Flawil, Switzerland) at ambient temperature.
The antimicrobial activity of the crude extracts was evaluated by bioassays using stocks solutions
with a concentration of 1% w/v (equivalent to 10 mg/mL in methanol). The bioassays of antibacterial
and antifungal activities were performed following a procedure described by Schneemann et al. [36].
Aliquot of 5 µL of each crude extract was added in each well of the 96-well microtiter plate and then
the solvent was evaporated using vacuum centrifuge (Biotage SPE Dry, Uppsala, Sweden) before
append 195 µL of the test microbial suspension. The final concentration of each crude extract in the
bioassays was 250 µg/mL. The test organisms comprised of gram-positive bacteria: Staphylococcus
epidermidis DSM 20044T, methicillin–resistant Staphylococcus aureus DSM 18827, Pseudomonas aeruginosa
DSM 50071T, and Propionibacterium acnes DSM 1897T, gram-negative bacteria: Xanthomonas campestris
DSM 2405 and Erwinia amylovora DSM 50901, and fungi: Candida albicans DSM 1386, Trichophyton
rubrum, Septoria tritici, and Phytophthora infestans. Trichophyton rubrum was obtained from F. Horter
(Department of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein,
Kiel, Germany while Septoria tritici and Phytophthora infestans were obtained from Dr. J. B. Speakman
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(BASF, Ludwigshafen, Germany). The positive control for the test bacteria was 100 µg/well of
chloramphenicol and that for the test fungi was 200 µg/well of cycloheximide, while the negative
control was no compound applied.
The cytotoxicity test was performed following a method described by Schulz et al. [19]. Aliquot
(1 µL) of each crude extract was added in a final assay volume of 100 µL of the mouse fibroblasts
(NIH-3T3) and hepatocellular carcinoma (HepG2 ACC 180) cell lines. NIH-3T3 cell line was provided
by G. Rimbach, University of Kiel, Germany while HepG2 ACC 180 was obtained from Leibniz
Institute DSMZ-German collection of microorganisms and cell cultures, Braunschweig, Germany. The
final concentration of each crude extract in the bioassays was 100 µg/mL. The positive control for
these assays was tamoxifen with a final concentration of 40 µM. No compound was added for the
negative control.
2.3.3. Profiling of Metabolites in Crude Extracts
The crude extracts dissolved in methanol were elucidated by analytical reversed-phase
HPLC-UV-MS (High-Performance Liquid Chromatography with UV detector coupled to Mass
Spectrometry), in a VWR-Hitachi La-Chrom Elite System, coupled to a diode array detector and
a Phenomenex Onyx Monolithic column (C18, 100 × 3.00 mm) according to the conditions described
by Silber et al. [37]. For the mass detection, the HPLC system was coupled to an ion trap detector
(Esquire4000, Bruker Daltonics, Billerica, MA, USA). The UV-Vis spectra of peaks obtained from each
bacterial crude extract were compared with the Dictionary of Natural Products 2012 [38].
3. Results and Discussion
3.1. Selective Isolation and Identification of the Isolates
A number of 30 and 46 isolates were obtained from soils samples of sites H0 and H6, respectively.
These isolates were obtained from plates with 10 fold dilutions, and 97% (74 isolates) of them were
found to be affiliated with the phylum Actinobacteria based on the 16S rRNA gene sequence similarity.
Two isolates were classified as Bacillus and Pseudomonas, while the others belong to Nocardiopsis
(7 isolates), Micromonospora (2 isolates), and Streptomyces (65 isolates) (Table 1).
Table 1. 16S rRNA gene-based identification of all bacteria isolated from Salar de Huasco.
Class Family Genus Number of Isolate (%) Site of Isolation
Actinobacteria
Streptomycetaceae Streptomyces 65 (86%) H0 and H6
Nocardiopsaceae Nocardiopsis 7 (9%) H0
Micromonosporaceae Micromonospora 2 (3%) H0
Bacilli Bacillaceae Bacillus 1 (1%) H0
Gammaproteobacteria Pseudomonadaceae Pseudomonas 1 (1%) H0
The eleven non-Streptomyces isolates were found only in the soil sample with neutral pH 7.6
collected from site H0, while the majority of the Streptomyces isolates (40) were obtained from the
hypersaline site H6 with pH 8.6. All 65 Streptomyces isolates were subdivided into three color grouping
after incubation on ISP3 agar medium at 28 ◦C for 14 days (Table 2). They showed the typical
morphology of the genus Streptomyces in formation of aerial mycelium and spore chains. Most of
these isolates produced diffusible pigments and excreted colored aqueous droplets on the hydrophobic
surface of their colonies.
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Table 2. Morphological and molecular characteristics of some Streptomyces spp. a isolated from Salar de Huasco.
Isolate
Code
Site of
Isolation
Morphological Characteristics b Molecular Characteristics
Aerial Spore Mass SubstrateMycelium
Diffusible
Pigments Closest Type Strain
16 rRNA Gene
Accession Number
Similarity
(%)
NRPS
(Adenylation
Domain)
HST05 H6 White Light yellowishpink - Streptomyces canus DSM 40017
T KQ948708 96.8 +
HST09 H6 Dark greyish blue Deep purplish red - Streptomyces lienomycini LMG 20091T AJ781353 99.6 +
HST14 H6 White Pale violet Light greyishbrown Streptomyces atroolivaceus NRRL ISP-5137
T JNXG01000049 96.0 -
HST18 H6 - Dark olive green Moderateyellow green Streptomyces alboniger NRRL B-1832
T LIQN01000245 96.7 +
HST19 H6 Dark greyish blue Dark greenishyellowish green
Dark greyish
yellowish
brown
Streptomyces collinus NBRC 12759T AB184123 99.2 +
HST21 H6 White Greyish yellow Moderate olivebrown Streptomyces albidochromogenes NBRC 101003
T AB249953 99.1 +
HST22 H6 White Deep orange yellow Moderate olivebrown Streptomyces albidochromogenes NBRC 101003
T AB249953 99.0 +
HST23 H6 Light pink Light orange yellow Dark yellow Streptomyces purpureus NBRC 13927T AB184547 98.8 -
HST28 H6 White Light olive brown Dark brown Streptomyces kanamyceticus NBRC 13414T AB184388 98.8 +
HST50 H6 White Greyish reddishbrown - Streptomyces ambofaciens ATCC 23877
T CP012382 96.0 -
HST51 H6 Light pink Strong yellowishbrown - Streptomyces alboniger NRRL B-1832
T LIQN01000245 98.6 +
HST54 H6 White Deep red Light greyishbrown Streptomyces griseolus NRRL B-2925
T JOFC01000069 97.6 -
HST61 H6 Pale yellowish pink Pale orange yellow - Streptomyces kanasensis ZX01T JN572690 99.6 -
HST66 H6 White Deep greenishyellow - Streptomyces fumanus NBRC 13042
T AB184273 96.9 +
HST68 H6 Greyish blue Pinkish grey - Streptomyces ambofaciens ATCC 23877T CP012382 96.0 +
HST69 H0 White Brilliant yellow - Streptomyces chlorus BK125T LIQN01000245 98.1 +
HST72 H0 White Strong yellowishbrown Strong brown Streptomyces microflavus NBRC 13062
T AB184284 97.9 -
HST82 H0 White Pale yellowish pink - Streptomyces cyaneofuscatus NRRL B-2570T JOEM01000050 95.6 -
HST83 H0 White Strong yellowishbrown Strong brown Streptomyces pratensis ch24
T JQ806215 97.8 +
a These Streptomyces isolates were selected based on the quality of their 16S rRNA gene sequences (>1300 nt). b The morphological characteristics were observed after growing Streptomyces
isolates on ISP3 agar medium at 28 ◦C for 14 days.
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Nineteen out of 65 Streptomyces isolates were selected for further study based on their nearly
complete 16S rRNA gene sequences (>1300 bp). These 19 isolates widely distributed across the
phylogenetic tree of the genus Streptomyces supported by high bootstrap values as shown in Figure 2.
A total of 12 isolates showed a 16S rRNA gene sequence similarity below the 98.7% threshold for
proposing as novel species [39] (Table 2), while the other seven (HST09, HST19, HST21, HST22, HST23,
HST28, and HST61) found to occupy distinct phylogenetic positions from their closest relatives with
no close relationship with any species and type strains of the genus Streptomyces from the Atacama
Desert described so far [11–15] (Figure 2).
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Figure 2. Neighbor-j ining phylogen tic tree based on almost complete 16S RNA sequences (> nt)
of the 19 Streptomyces isolate derived from Salar de Huasco and their closely related species. The tree
was constructed using the Neighbor-Joining algorithm and the Jukes–Cantor substitution model. The
scale bar indicates 0.005 substitutions per nucleotide, and Streptomyces albus subsp. albus DSM 40313T
was used as an out-group. Bootstrap values above 50% are present.
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Isolate HST19 forms a distinct branch closely related to the type strain of Streptomyces collinus
NBRC 12759T (99.2%) [40], Streptomyces iakyrus NRRL ISP-5482T (98.8%) [41], and Streptomyces
violaceochromogenes NBRC 13100T (99.3%) [42]. Isolates HST21 and HST22 form a well-supported
sub-clade closely associated to Streptomyces albidochromogenes NBRC 101003T (99.0%) [43]. Strain HST61
occupied a phylogenetic position close to “Streptomyces kanasensis” ZX01 (99.6%) which is a producer
of a novel antiviral glycoprotein [44]. Isolate HST28 showed close phylogenetic relationship with
Streptomyces kanamyceticus NBRC 13414T (98.8%) [45], while isolate HST23 had close relatedness to
Streptomyces purpureus NBRC 13927T (98.8%) [46]. Isolates HST09 occupied distant subclade closely
related to Streptomyces lienomycini LMG 20091T (99.6%) [43].
The length of the branch of all Streptomyces isolates in the phylogenetic tree and the assignation to
these isolates to completely different clades from each other, except for isolates HST21 and HST22,
highlight the divergence of them from their closely related neighbors. Further studies need to be
performed to confirm the right affiliations of these isolates to the novel species within the evolutionary
radiation of the genus Streptomyces.
Most isolates (except for isolates HST83, HST72, HST21, and HST22) showed divergent
phylogenetic positions compared to the type species of the genus Streptomyces (Figure 2). Therefore,
these strains should be designed for further taxonomic and analytical chemistry analyses to confirm
their novelty at species rank and as a source of novel chemical entities (Table 3).
Table 3. Bioactivities of crude extracts derived from Streptomyces spp. of Salar de Huasco.
Crude Extract
Derived From
Streptomyces
Isolate Grown in
Different Media
Growth Inhibition (%) a
Antibacterial Activity
Antifungal Activity CytotoxicityGram-Positive Bacteria Gram-Negative Bacteria
Se MRSA Pa Xc Ea Ca Tru Sep PhA NIH-3T3 HepG2
HST09-GYM 96 92 - 27 - - 72 - - 99 79
HST09-SPM 28 28 - - - - - - - 36 -
HST14-GYM - - - - - - 33 - - 50 40
HST14-SPM - - - - - - 30 - - 51 42
HST19-GYM - - 57 55 - - 58 - - 57 34
HST19-SPM 61 60 53 76 - - - - - 20 -
HST21-GYM 99 98 - 84 91 - 86 22 50 99 99
HST21-SPM 97 95 - 79 96 - 100 - 53 99 99
HST23-GYM 93 92 100 97 71 77 100 100 49 99 99
HST23-SPM 98 97 97 99 97 76 100 100 49 99 99
HST28-GYM 97 98 100 100 22 45 37 94 27 100 100
HST28-SPM 100 100 100 100 - 39 29 89 25 97 100
HST50-GYM 96 - 90 97 92 - 41 29 - 43 38
HST50-SPM 93 41 97 98 - - 57 30 - - -
HST54-GYM 96 95 96 78 - - 48 - 39 53 24
HST54-SPM 95 92 93 71 - - 47 - 35 52 25
HST61-GYM 73 - - 76 63 - 59 59 22 - -
HST61-SPM 81 41 - 62 68 - 43 62 26 - -
HST68-GYM 93 - 90 97 91 - 30 21 - - 21
HST68-SPM 38 - 50 24 - - 45 - - - -
HST72-GYM 95 97 98 35 - 28 60 100 47 97 69
HST72-SPM 97 97 99 56 - - 50 96 28 86 59
HST82-GYM 100 97 90 92 - - 41 - - 50 40
HST82-SPM - 47 - - - - 26 - - 39 38
a The average results derived from triplicate assays are shown with inhibition percentage (%) of growth of
Se (Staphylococcus epidermis), MRSA (methicillin-resistant Staphylococcus aureus), Pa (Propionibacterium acnes), Xc
(Xanthomonas campestris), Ea (Erwinia amylovora), Ca (Candida albicans), Tru (Trichophyton rubrum), Sep (Septoria tritici),
Pha (Phytophthora infestans), NIH-3T3 (mouse fibroblasts), and HepG2 (hepatocellular carcinoma). GYM and SPM
refer respectively to glucose yeast extract plus malt extract medium and starch-soy peptone medium, in which the
Streptomyces isolates were grown before the preparation of their crude extracts. The negative results are shown with (-).
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3.2. Secondary Metabolite Analysis
The NRPSs are multimodular enzymatic complexes constituted by three main catalytic domains:
The adenylation (A) domain, responsible for the recognition and activation of a specific amino acid,
the condensation (C) domain catalyses the formation of the peptidic bond (C-N) between different
modules, and the peptidyl-carrier (T) domain which transfers the activated amino acids from the
A domain to the C domain of the same module [6]. The presence of A domain in actinobacterial
genomes reflects the biosynthesis of secondary metabolites. The products of the NRPS biosynthetic
pathway are diverse secondary metabolites including several antitumor compounds [47,48]. A total of
12 Streptomyces isolates (63%) (Table 2) revealed the possession of NRPS A domain. A correlation has
been previously observed between the numbers of isolates with the positive NRPS-PCR reaction and
the production of bioactive compounds [36]. The 12 NRPS-holding isolates were tested further for
their bioactivities. Isolates HST05, HST14, HST18 and HST51 were discarded from this analysis due to
their low growth rate on the test media. From the pairs of isolates HST83-HST72 and HST21-HST22
that occupied the same phylogenetic position (Figure 2), we only included isolates HST21 and HST72
for the bioactivity tests.
The crude extracts obtained from Streptomyces isolates grown previously in GYM or SPM broth
demonstrated the different HPLC profiles (Figure S1). These isolates have a wide range of metabolites
in their chromatograms (Figure S1). The UV-Vis and MS data of the crude extracts in comparison with
the Dictionary of Natural Products Database exhibited a low similarity to the known compounds, which
highlights the novelty of these natural entities. The majority of the isolates showed high antifungal,
antibacterial and cytotoxic activities (Table 3), supported by the high levels of growth inhibition (>90%)
against several pathogens, such as, MRSA (HST09, HST21, HST23, HST28, HST72, HST82, HST50,
HST54, and HST68), P. acnes (HST23, HST23, HST28, HST50, HST54, and HST72), X. campestris (HST23,
HST28, HST50, and HST68), and Trichophyton rubrumn (HST21 and HST23). The crude extracts at a
final extract concentration of 100 µg/mL from isolates HST09, HST21, HST23, HST28, HST66, and
HST72 also showed the high levels of cytotoxicity (~99%) against the tumor cell lines of HepG2 and
NIH-3T3. Based on the overall bioactivities, isolates HST21, HST23, and HST28 were the producers of
broad-spectrum antibiotics. These results are coherent with those described Streptomyces spp. isolated
from the other Salar sites of the Atacama Desert, e.g., Streptomyces sp. C38 from Salar de Atacama
that produces atacamycins A–C [17] and Streptomyces sp. DB634 from Salar de Tara that produces
abenquines A–D [19].
The polyextreme ecosystem of Salar de Huasco forces the microorganisms to adapt to it [49],
which led to the development of unique Streptomyces taxa that are clearly different from the other sites
in the Atacama Desert and the Altiplano [9] and probably vary due to the spatial heterogeneity within
the same area [50].
4. Conclusions
Streptomyces spp. isolated from the Salar de Huasco at the Chilean Altiplano showed taxonomic
divergences from the species with validly published names and capabilities to produce novel secondary
metabolites with interesting pharmaceutical potentials. These findings open up the prospect for novel
drug discovery. Further analytical and chemical analyses should be carried out to elucidate these
microbial products in order to be exploited for future biotechnological applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/1424-2818/11/5/69/s1,
Figure S1: HPLC-UV/Vis Chromatographic profiles of extracts obtained from culture metabolic extracts for
analyzed strains, which were grown in liquid media GYM (A) and SPM (B) both of them at 2% NaCl.
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